(Q28246959)

English

Inhibition of inducible nitric-oxide synthase by activators of AMP-activated protein kinase: a new mechanism of action of insulin-sensitizing drugs

scientific article (publication date: 14 May 2004)

In more languages

Statements

scholarly article

0 references

Inhibition of inducible nitric-oxide synthase by activators of AMP-activated protein kinase: a new mechanism of action of insulin-sensitizing drugs (English)

0 references

1 reference

based on heuristic

inferred from title

author name string

Geneviève Pilon

1

0 references

Patrice Dallaire

2

0 references

André Marette

3

0 references

language of work or name

0 references

publication date

14 May 2004

0 references

Journal of Biological Chemistry

0 references

279

0 references

20

0 references

20767-74

0 references

Management of cellular energy by the AMP-activated protein kinase system

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Activation of yeast Snf1 and mammalian AMP-activated protein kinase by upstream kinases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Invited review: intracellular signaling in contracting skeletal muscle

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

AMP-activated protein kinase: possible target for treatment of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Acute and chronic treatment of ob/ob and db/db mice with AICAR decreases blood glucose concentrations.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

5-aminoimidazole-4-carboxy-amide-1-beta-D-ribofuranoside treatment ameliorates hyperglycaemia and hyperinsulinaemia but not dyslipidaemia in KKAy-CETP mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Is type II diabetes mellitus a disease of the innate immune system?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Cytokines modulate glucose transport in skeletal muscle by inducing the expression of inducible nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Role of host phosphotyrosine phosphatase SHP-1 in the development of murine leishmaniasis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Fluorometric assay of nitrite and nitrate in brain tissue after traumatic brain injury and cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Expression of nitric oxide synthase in skeletal muscle: a novel role for nitric oxide as a modulator of insulin action

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Increased adenosine concentration in blood from ischemic myocardium by AICA riboside. Effects on flow, granulocytes, and injury

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Nitric oxide and macrophage function

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

The role of nitric oxide in innate immunity.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Inducible nitric oxide synthase: what difference does it make?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Nitric oxide and inflammatory joint diseases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Role of nitric oxide in obesity-induced beta cell disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Targeting the AMP-activated protein kinase for the treatment of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

The role of nitric oxide in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Involvement of inducible nitric oxide synthase in the inflammatory process of myocardial infarction

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Ileus in critical illness: mechanisms and management

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Pathophysiological role of nitric oxide in rat experimental colitis.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Signalling events involved in interferon-gamma-inducible macrophage nitric oxide generation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Induction of iNOS expression in skeletal muscle by IL-1beta and NFkappaB activation: an in vitro and in vivo study

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Ubiquitination of inducible nitric oxide synthase is required for its degradation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Ubiquitination of neuronal nitric-oxide synthase in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401390200

21 January 2018

Identifiers

10.1074/JBC.M401390200

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28246959&oldid=1237787351"